S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AXSM Axsome Therapeutics Inc

91.00

1.26 (1.40%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics (NASDAQ:AXSM)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Axsome Therapeutics Charts.

Axsome Therapeutics Inc News

Form 8-K - Current report
Tuesday 26 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in ENCORE Long-Term Phase 3 Trial in Narcolepsy
Tuesday 26 November 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
Friday 8 November 2024 (1 month ago) • GlobeNewswire Inc.

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
Tuesday 29 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Thursday 24 October 2024 (2 months ago) • Edgar (US Regulatory)

Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
Tuesday 15 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 1 October 2024 (3 months ago) • Edgar (US Regulatory)

Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
Tuesday 24 September 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 4 September 2024 (4 months ago) • Edgar (US Regulatory)

More Axsome Therapeutics Inc News Articles

Intergrated Cannabis Sol... (PK)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Bioelectronics (PK)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions